Find More Contacts for Azevan Pharmaceuticals
Protected Content
Manager Operations
2 emails found
View contacts for Azevan Pharmaceuticals to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Phone Number 6104658638

Azevan Pharmaceuticals, Inc., a clinical stage, small molecule drug development company, develops therapeutics to treat disorders of stress, mood, and behavior. The company specializes in clinical compounds that selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of major depression,

intermittent explosive disorder, impulse control/anger disorders, and post-traumatic stress disorder (PTSD). Its products include SRX251 and SRX246 CNS-penetrating V1a receptor antagonists that are orally bioavailable. The company's SRX246 and SRX251 are developed for stress-related CNS disorders, including depression, PTSD, and intermittent explosive disorders. Azevan Pharmaceuticals, Inc. was formerly known as Serenix Pharmaceuticals, LLC and changed its name to Azevan Pharmaceuticals, Inc. in January 2002. The company was founded in 1999 and is based in Bethlehem, Pennsylvania.

Lists Featuring This Company

Pennsylvania Companies With Less Than $50M in Revenue (Top 10K)
9,483 Number of Organizations • $38.5B Total Funding Amount • 4,330 Number of Investors
Pennsylvania Companies With Less Than $1B in Revenue (Top 10K)
9,976 Number of Organizations • $68.5B Total Funding Amount • 4,731 Number of Investors
Biotechnology Companies With Less Than $500M in Revenue (Top 10K)
9,995 Number of Organizations • $615.4B Total Funding Amount • 41,300 Number of Investors
Therapeutics Companies With More Than $10M in Revenue
2,118 Number of Organizations • $138.5B Total Funding Amount • 3,724 Number of Investors

Frequently Asked Questions

Where is Azevan Pharmaceuticals's headquarters? Azevan Pharmaceuticals is located in Bethlehem, Pennsylvania, United States.How much funding has Azevan Pharmaceuticals raised to date? Azevan Pharmaceuticals has raised .When was the last funding round for Azevan Pharmaceuticals? Azevan Pharmaceuticals closed its last funding round on Oct 18, 2013 from a Venture - Series Unknown round.Who are Azevan Pharmaceuticals's competitors? Alternatives and possible competitors to Azevan Pharmaceuticals may include Milestone PharmaceuticalsAVEO Oncology, and Aclaris Therapeutics.